oxiglutatione

Small moleculeapproved

Approved

Jul 24, 2008

Oxiglutathione is the oxidized disulfide form of glutathione (GSH) with potential protective activity. Glutathione disulfide (GSSG) is reduced by glutathione reductase to GSH. GSSG and GSH together play important roles in numerous redox reactions, such as those involved in the detoxification of harmful substances and free radicals, and in reactions preventing oxidative damage in erythrocytes. Upon ocular administration in irrigation solution, glutathione disulfide may exert a beneficial effect on the intracellular redox state of glutathione, thereby protecting the integrity and barrier function of the corneal endothelial cells. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 2 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

2000s

  1. Jul 24, 2008

    Alcon — Earliest FDA Approval

  2. Jul 24, 2008

    Alcon — NDA Secondary Org

  3. Jul 24, 2008

    Alcon — NDA Organization

  4. Jul 24, 2008

    Nestle — NDA Secondary Org

Indications

Mechanism of action

Combination products

Approval history

  • approvedJul 24, 2008

Chemistry & pharmacology

Loading structure…

SMILES

[H+].[H+].[Na+].[Na+].N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C([O-])=O)C(=O)NCC([O-])=O)C(=O)NCC([O-])=O)C([O-])=O
Mol. weight
656.595 g/mol
Lipinski Ro5
3 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Availability
Prescription Only

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • nov002
  • nov 002
  • nov-002
  • nov-002
  • nov-002
  • nov-002
  • oxidized glutathione
  • oxidized glutathione
  • oxiglutatione
  • oxiglutatione
  • oxiglutatione
  • oxiglutatione
  • oxiglutatione
  • oxiglutatione
  • oxiglutatione

Organizations

Marketing (3)

OrganizationOrg typeRelationshipDate
AlconFor profitNDA2Jul 24, 2008
AlconFor profitNDAJul 24, 2008
NestleFor profitNDA2Jul 24, 2008